Terms: = Bone cancer AND MAFB, Q9Y5Q3, 9935, ENSG00000204103, MGC43127, KRML
17 results:
1. Circ_0051079 functions as an oncogenic regulator in osteosarcoma by leading to mafb expression upregulation by competitively interacting with miR-1286.
Huang Z; Chen P; Jia R; Liu Y
J Orthop Surg Res; 2022 Sep; 17(1):428. PubMed ID: 36153605
[TBL] [Abstract] [Full Text] [Related]
2. ZNF750 facilitates carcinogenesis via promoting the expression of long non-coding RNA
Xia L; Lin H; Zhou Y; Lian J
J Zhejiang Univ Sci B; 2022 Jul; 23(7):587-596. PubMed ID: 35794688
[TBL] [Abstract] [Full Text] [Related]
3. Local anesthetic levobupivacaine inhibits stemness of osteosarcoma cells by epigenetically repressing mafb though reducing KAT5 expression.
Wang Z; Song Y; Zhang H; Yang Y; Zhang S; Wang W
Aging (Albany NY); 2022 Mar; 14(6):2793-2804. PubMed ID: 35333774
[TBL] [Abstract] [Full Text] [Related]
4. Functional analysis of large MAF transcription factors and elucidation of their relationships with human diseases.
Takahashi S
Exp Anim; 2021 Aug; 70(3):264-271. PubMed ID: 33762508
[TBL] [Abstract] [Full Text] [Related]
5. Small extracellular vesicles deliver osteolytic effectors and mediate cancer-induced osteolysis in bone metastatic niche.
Ma Q; Liang M; Wu Y; Dou C; Xu J; Dong S; Luo F
J Extracell Vesicles; 2021 Feb; 10(4):e12068. PubMed ID: 33659051
[TBL] [Abstract] [Full Text] [Related]
6. High-risk cytogenetics in multiple myeloma: Further scrutiny of deletions within the IGH gene region enhances risk stratification.
Smith SC; Althof PA; Dave BJ; Sanmann JN
Genes Chromosomes Cancer; 2020 Oct; 59(10):569-574. PubMed ID: 32447782
[TBL] [Abstract] [Full Text] [Related]
7. mafb Promotes cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop.
Chen Y; Wang T; Huang M; Liu Q; Hu C; Wang B; Han D; Chen C; Zhang J; Li Z; Liu C; Lei W; Chang Y; Wu M; Xiang D; Chen Y; Wang R; Huang W; Lei Z; Chu X
Cancer Res; 2020 Jun; 80(12):2472-2483. PubMed ID: 32234710
[TBL] [Abstract] [Full Text] [Related]
8. mafb protein confers intrinsic resistance to proteasome inhibitors in multiple myeloma.
Qiang YW; Ye S; Huang Y; Chen Y; Van Rhee F; Epstein J; Walker BA; Morgan GJ; Davies FE
BMC Cancer; 2018 Jul; 18(1):724. PubMed ID: 29980194
[TBL] [Abstract] [Full Text] [Related]
9. High prevalence of immunoglobulin light chain gene aberrations as revealed by FISH in multiple myeloma and MGUS.
Türkmen S; Binder A; Gerlach A; Niehage S; Theodora Melissari M; Inandiklioglu N; Dörken B; Burmeister T
Genes Chromosomes Cancer; 2014 Aug; 53(8):650-6. PubMed ID: 24729354
[TBL] [Abstract] [Full Text] [Related]
10. Rapamycin inhibits osteoclast formation in giant cell tumor of bone through the C/EBPβ - mafb axis.
Smink JJ; Tunn PU; Leutz A
J Mol Med (Berl); 2012 Jan; 90(1):25-30. PubMed ID: 22071989
[TBL] [Abstract] [Full Text] [Related]
11. Distinguishing primary and secondary translocations in multiple myeloma.
Gabrea A; Leif Bergsagel P; Michael Kuehl W
DNA Repair (Amst); 2006 Sep; 5(9-10):1225-33. PubMed ID: 16829212
[TBL] [Abstract] [Full Text] [Related]
12. Early genetic events provide the basis for a clinical classification of multiple myeloma.
Kuehl WM; Bergsagel PL
Hematology Am Soc Hematol Educ Program; 2005; ():346-52. PubMed ID: 16304402
[TBL] [Abstract] [Full Text] [Related]
13. Molecular pathogenesis and a consequent classification of multiple myeloma.
Bergsagel PL; Kuehl WM
J Clin Oncol; 2005 Sep; 23(26):6333-8. PubMed ID: 16155016
[TBL] [Abstract] [Full Text] [Related]
14. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma.
Bergsagel PL; Kuehl WM; Zhan F; Sawyer J; Barlogie B; Shaughnessy J
Blood; 2005 Jul; 106(1):296-303. PubMed ID: 15755896
[TBL] [Abstract] [Full Text] [Related]
15. Advances in biology of multiple myeloma: clinical applications.
Hideshima T; Bergsagel PL; Kuehl WM; Anderson KC
Blood; 2004 Aug; 104(3):607-18. PubMed ID: 15090448
[TBL] [Abstract] [Full Text] [Related]
16. Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasia.
Miura K; Iida S; Hanamura I; Kato M; Banno S; Ishida T; Kusumoto S; Takeuchi G; Miwa H; Nitta M; Inagaki H; Eimoto T; Nomura K; Taniwaki M; Ueda R
Cancer Sci; 2003 Apr; 94(4):350-4. PubMed ID: 12824903
[TBL] [Abstract] [Full Text] [Related]
17. A xeno-transplantable plasma cell leukemia line with a split translocation of the IgH gene.
Ohbayashi K; Taniwaki M; Ninomiya M; Kiyoi H; Iida S; Ueda R; Naoe T
Cancer Genet Cytogenet; 2003 Jul; 144(1):31-5. PubMed ID: 12810253
[TBL] [Abstract] [Full Text] [Related]
